Aldeyra Therapeutics
ALDX
ALDX
96 hedge funds and large institutions have $232M invested in Aldeyra Therapeutics in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 24 increasing their positions, 36 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 36
42% less call options, than puts
Call options by funds: $1.52M | Put options by funds: $2.61M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
96
Holding in Top 10
1
Calls
$1.52M
Puts
$2.61M
Top Buyers
| 1 | +$2.25M | |
| 2 | +$2.18M | |
| 3 | +$1.42M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$852K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$790K |
Top Sellers
| 1 | -$6.64M | |
| 2 | -$5.87M | |
| 3 | -$4.67M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$2.98M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$2.45M |